Floatz logo

VITPSO

Rising Prostate Specific Antigen (PSA)

Tyme, IncSmall moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Rising Prostate Specific Antigen (PSA) cohort.

Asset / SponsorPhaseRating
sm88
Tyme, Inc
Phase 1/2CCC
Rapamycin
Tyme, Inc
Phase 1/2CCC
PHENYTOIN
Tyme, Inc
Phase 1/2CCC

Same molecule, other indications

VITPSO is also rated in:

primary cutaneous T-cell non-Hodgkin lymphomaDormant
BB
Indicative ·
67 / 100
View asset →
mycosis fungoidesDormant
BB
Indicative ·
67 / 100
View asset →
Metastatic Pancreatic AdenocarcinomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →